{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:08:26Z","timestamp":1788869306183,"version":"build-2803163510"},"reference-count":71,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.beem.2026.102097","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:30:42Z","timestamp":1773250242000},"page":"102097","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Familial prolactinomas"],"prefix":"10.1016","volume":"40","author":[{"given":"Olga","family":"Papalou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rta","family":"Korbonits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2026.102097_bib1","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/cen.14053","article-title":"Clinical genetic testing in endocrinology: current concepts and contemporary challenges","volume":"91","author":"Newey","year":"2019","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2026.102097_bib2","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S2213-8587(25)00227-X","article-title":"Prolactin-secreting adenomas: pathogenesis, diagnosis, and management","volume":"13","author":"Fleseriu","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2026.102097_bib3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41574-023-00949-7","article-title":"Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 2, specific diseases","volume":"20","author":"Korbonits","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2026.102097_bib4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s12020-021-02633-0","article-title":"The clinical aspects of pituitary tumour genetics","volume":"71","author":"Denes","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2026.102097_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12022-022-09742-0","article-title":"The spectrum of familial pituitary neuroendocrine tumors","volume":"34","author":"Armeni","year":"2023","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2026.102097_bib6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/cen.14706","article-title":"Molecular genetic testing in the management of pituitary disease","volume":"97","author":"Coopmans","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2026.102097_bib7","doi-asserted-by":"crossref","first-page":"e2247","DOI":"10.1210\/clinem\/dgaa040","article-title":"Significant benefits of AIP testing and clinical screening in familial isolated and young-onset pituitary tumors","volume":"105","author":"Marques","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102097_bib8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1210\/er.2012-1013","article-title":"Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene","volume":"34","author":"Beckers","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2026.102097_bib9","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa1408028","article-title":"Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation","volume":"371","author":"Trivellin","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beem.2026.102097_bib10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40478-016-0328-1","article-title":"Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study","volume":"4","author":"Iacovazzo","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.beem.2026.102097_bib11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1530\/ERC-17-0131","article-title":"Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing's disease","volume":"24","author":"Hernandez-Ramirez","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2026.102097_bib12","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ajhg.2017.03.011","article-title":"Germline mutations in CDH23, encoding cadherin-related 23, are associated with both familial and sporadic pituitary adenomas","volume":"100","author":"Zhang","year":"2017","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.beem.2026.102097_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1166076","article-title":"Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion","volume":"14","author":"Trivellin","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.beem.2026.102097_bib14","series-title":"AIP Familial Isolated Pituitary Adenomas","author":"Korbonits","year":"1993"},{"key":"10.1016\/j.beem.2026.102097_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mce.2010.05.001","article-title":"AIP gene and familial isolated pituitary adenomas","volume":"326","author":"Ozfirat","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.beem.2026.102097_bib16","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1210\/jc.2006-2513","article-title":"Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families","volume":"92","author":"Daly","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102097_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11102-020-01085-5","article-title":"AIP variant causing familial prolactinoma","volume":"24","author":"Carty","year":"2021","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2026.102097_bib18","doi-asserted-by":"crossref","first-page":"E1242","DOI":"10.1210\/jc.2015-1869","article-title":"Landscape of familial isolated and young-onset pituitary adenomas: prospective diagnosis in AIP mutation carriers","volume":"100","author":"Hernandez-Ramirez","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102097_bib19","doi-asserted-by":"crossref","first-page":"E373","DOI":"10.1210\/jc.2009-2556","article-title":"Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study","volume":"95","author":"Daly","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102097_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1242588","article-title":"The clinical and therapeutic profiles of prolactinomas associated with germline pathogenic variants in the aryl hydrocarbon receptor interacting protein (AIP) gene","volume":"14","author":"Vroonen","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2026.102097_bib21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2265.1995.tb02666.x","article-title":"Familial prolactinoma","volume":"42","author":"Berezin","year":"1995","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2026.102097_bib22","first-page":"181","article-title":"Clinical and genetic studies of a three-member familial isolated pituitary adenoma with homogeneous prolactinomas","volume":"80","author":"Vacchiano","year":"2020","journal-title":"Medicina"},{"key":"10.1016\/j.beem.2026.102097_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1305606","article-title":"PAM variants in patients with thyrotrophinomas, cyclical Cushing's disease and prolactinomas","volume":"14","author":"De Sousa","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2026.102097_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-08610-1","article-title":"Aryl hydrocarbon receptor interacting protein and syndromic gene variants detected in Turkish isolated pituitary adenoma families by whole exome sequencing","volume":"15","author":"Ertorer","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.beem.2026.102097_bib25","article-title":"Germline genetic variants in young-onset sporadic pituitary macroadenomas: a multigene panel analysis","volume":"40","author":"Gaspar","year":"2025","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.beem.2026.102097_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/endrev\/bnaa031","article-title":"Multiple endocrine neoplasia type 1: latest insights","volume":"42","author":"Brandi","year":"2021","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2026.102097_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ando.2023.09.003","volume":"85","author":"Goudet","year":"2024","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.beem.2026.102097_bib28","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1093\/ejendo\/lvaf247","article-title":"New directions in MEN1 management: navigating the new clinical practice guidelines","volume":"193","author":"Papalou","year":"2025","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2026.102097_bib29","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S2213-8587(25)00118-4","article-title":"Treatments for MEN1-associated endocrine tumours: three systematic reviews and a meta-analysis","volume":"13","author":"English","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2026.102097_bib30","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-8587(25)00119-6","article-title":"Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practice","volume":"13","author":"Brandi","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2026.102097_bib31","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0603877103","article-title":"Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans","volume":"103","author":"Pellegata","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beem.2026.102097_bib32","doi-asserted-by":"crossref","first-page":"T195","DOI":"10.1530\/ERC-17-0243","article-title":"MEN4 and CDKN1B mutations: the latest of the MEN syndromes","volume":"24","author":"Alrezk","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2026.102097_bib33","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1210\/clinem\/dgac162","article-title":"MEN4, the MEN1 mimicker: a case series of three phenotypically heterogenous patients with unique CDKN1B mutations","volume":"107","author":"Seabrook","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102097_bib34","doi-asserted-by":"crossref","first-page":"e1482","DOI":"10.1210\/clinem\/dgae055","article-title":"Beyond MEN1, when to think about MEN4? retrospective study on 5600 patients in the French population and literature review","volume":"109","author":"Chevalier","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102097_bib35","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2008-2083","article-title":"Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states","volume":"94","author":"Agarwal","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102097_bib36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11102-025-01607-z","article-title":"Loss of heterozygosity and absence of MAX immunostaining in a prolactinoma associated with multiple endocrine neoplasia type 5 (MEN5)","volume":"28","author":"Delemer","year":"2025","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2026.102097_bib37","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ng.861","article-title":"Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma","volume":"43","author":"Comino-Mendez","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2026.102097_bib38","article-title":"Multiple endocrine neoplasia type 5 due to germline MAX mutations: a systematic review of tumor spectrum and clinical features","author":"Charoenngam","year":"2025","journal-title":"Endocr Pr"},{"key":"10.1016\/j.beem.2026.102097_bib39","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s12020-025-04186-y","article-title":"Expanding the phenotype of multiple endocrine neoplasia type 5 (MEN5): pituitary gigantism, myelolipoma and familial pheochromocytoma due to a germline pathogenic MAX variant","volume":"88","author":"Haider","year":"2025","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2026.102097_bib40","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1210\/clinem\/dgaa957","article-title":"Multiple endocrine tumors associated with germline MAX mutations: multiple endocrine neoplasia type 5?","volume":"106","author":"Seabrook","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102097_bib41","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1530\/EJE-20-0054","article-title":"Germinal defects of SDHx genes in patients with isolated pituitary adenoma","volume":"183","author":"Mougel","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2026.102097_bib42","doi-asserted-by":"crossref","first-page":"E710","DOI":"10.1210\/jc.2014-4297","article-title":"Pituitary adenoma with paraganglioma\/pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and mice","volume":"100","author":"Xekouki","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102097_bib43","article-title":"A patient with a germline SDHB mutation presenting with an isolated pituitary macroprolactinoma","volume":"2018","author":"Maher","year":"2018","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.beem.2026.102097_bib44","doi-asserted-by":"crossref","first-page":"R157","DOI":"10.1530\/ERC-22-0157","article-title":"Succinate dehydrogenase and MYC-associated factor X mutations in pituitary neuroendocrine tumours","volume":"29","author":"Loughrey","year":"2022","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2026.102097_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1273093","article-title":"An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline SDHB pathogenic variant in the absence of paraganglioma or pheochromocytoma","volume":"14","author":"Alzahrani","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2026.102097_bib46","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s12022-017-9474-7","article-title":"Pituitary carcinoma in a patient with an SDHB mutation","volume":"28","author":"Tufton","year":"2017","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2026.102097_bib47","doi-asserted-by":"crossref","first-page":"E531","DOI":"10.1210\/jc.2014-3399","article-title":"Heterogeneous genetic background of the association of pheochromocytoma\/paraganglioma and pituitary adenoma: results from a large patient cohort","volume":"100","author":"Denes","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102097_bib48","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1046\/j.1365-2133.1997.d01-1239.x","article-title":"Carney complex: report of a kindred with predominantly cutaneous manifestations","volume":"136","author":"Armstrong","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.beem.2026.102097_bib49","doi-asserted-by":"crossref","first-page":"M85","DOI":"10.1530\/EJE-15-0209","article-title":"Carney complex: an update","volume":"173","author":"Correa","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2026.102097_bib50","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMoa043146","article-title":"Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)","volume":"352","author":"Hampel","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beem.2026.102097_bib51","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1210\/jc.2017-01401","article-title":"Corticotroph pituitary carcinoma in a patient with lynch syndrome (LS) and pituitary tumors in a nationwide LS cohort","volume":"102","author":"Bengtsson","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102097_bib52","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cancergen.2021.03.008","article-title":"Invasive ACTH-producing pituitary gland neoplasm secondary to MSH2 mutation","volume":"256-257","author":"Loughrey","year":"2021","journal-title":"Cancer Genet"},{"key":"10.1016\/j.beem.2026.102097_bib53","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae085","article-title":"Germline variants in sporadic pituitary adenomas","volume":"8","author":"Alzahrani","year":"2024","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.beem.2026.102097_bib54","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/02688697.2021.1967881","article-title":"Aggressive pituitary adenoma in the context of Lynch syndrome: a case report and literature review on this rare coincidence","volume":"38","author":"Teuber","year":"2024","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.beem.2026.102097_bib55","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ando.2011.12.001","article-title":"Von Hippel-Lindau disease and aggressive GH-PRL pituitary adenoma in a young boy","volume":"73","author":"Tudorancea","year":"2012","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.beem.2026.102097_bib56","first-page":"2720","article-title":"Increased prevalence of germline pathogenic CHEK2 variants in individuals with pituitary adenomas","volume":"109","author":"De Sousa","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102097_bib57","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1056\/NEJMoa1307557","article-title":"Mutant prolactin receptor and familial hyperprolactinemia","volume":"369","author":"Newey","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beem.2026.102097_bib58","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/hmg\/ddy396","article-title":"Association of prolactin receptor (PRLR) variants with prolactinomas","volume":"28","author":"Gorvin","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.beem.2026.102097_bib59","doi-asserted-by":"crossref","first-page":"6144","DOI":"10.18632\/oncotarget.23713","article-title":"Natural and molecular history of prolactinoma: insights from a Prlr(-\/-) mouse model","volume":"9","author":"Bernard","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.beem.2026.102097_bib60","article-title":"Is prolactin receptor signaling a target in dopamine-resistant prolactinomas?","volume":"13","author":"Ferraris","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.beem.2026.102097_bib61","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13023-020-01379-8","article-title":"Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH(4)) deficiencies","volume":"15","author":"Opladen","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.beem.2026.102097_bib62","first-page":"48","article-title":"High prolactin levels in dihydropteridine reductase deficiency: A sign of therapy failure or additional pathology?","volume":"61","author":"Vitturi","year":"2021","journal-title":"JIMD Rep"},{"key":"10.1016\/j.beem.2026.102097_bib63","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s13023-023-02963-4","article-title":"Late-onset symptomatic hyperprolactinemia in 6-pyruvoyl-tetrahydropterin synthase deficiency","volume":"18","author":"Hsu","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.beem.2026.102097_bib64","article-title":"L-dopa might be insufficient to suppress development of prolactinomas in dihydropteridine reductase-deficiency patients","volume":"2","author":"Diaz-Moreno","year":"2024","journal-title":"JCEM Case Rep"},{"key":"10.1016\/j.beem.2026.102097_bib65","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","article-title":"Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement","volume":"19","author":"Petersenn","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2026.102097_bib66","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41574-023-00948-8","article-title":"Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 1, general recommendations","volume":"20","author":"Korbonits","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2026.102097_bib67","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/EJE-12-0763","article-title":"Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis","volume":"168","author":"Cuny","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2026.102097_bib68","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1530\/EJE-21-0075","article-title":"Clinical and genetic characteristics in patients under 30 years with sporadic pituitary adenomas","volume":"185","author":"Martinez de LaPiscina","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2026.102097_bib69","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/ejendo\/lvad148","article-title":"Genetic testing in prolactinomas: a cohort study","volume":"189","author":"Boukerrouni","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2026.102097_bib70","doi-asserted-by":"crossref","first-page":"L37","DOI":"10.1530\/ERC-18-0065","article-title":"Pheochromocytomas and pituitary adenomas in three patients with MAX exon deletions","volume":"25","author":"Daly","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2026.102097_bib71","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/cen.14596","article-title":"A practical guide to genetic testing in endocrinology","volume":"97","author":"Izatt","year":"2022","journal-title":"Clin Endocrinol"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X26000187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X26000187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:19:34Z","timestamp":1788866374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X26000187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1521690X26000187"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2026.102097","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Familial prolactinomas","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2026.102097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102097"}}